Scarica l'app Stockscreener
7.32
4.44%
-0.34
Dopo l'orario di chiusura:
7.34
0.02
+0.27%
Precedente Chiudi:
$7.66
Aprire:
$7.78
Volume 24 ore:
40,654
Relative Volume:
0.37
Capitalizzazione di mercato:
$36.53M
Reddito:
$34.77M
Utile/perdita netta:
$-74.04M
Rapporto P/E:
-0.9266
EPS:
-7.9
Flusso di cassa netto:
$-79.76M
1 W Prestazione:
-5.55%
1M Prestazione:
+5.32%
6M Prestazione:
-41.78%
1 anno Prestazione:
-80.74%
Intervallo 1D:
$7.315
$7.85
Intervallo di 1 settimana:
$7.315
$8.09
Portata 52W:
$5.21
$70.75
Mersana Therapeutics Inc Stock (MRSN) Company Profile
Nome
Mersana Therapeutics Inc
Settore
Industria
Telefono
617-498-0020
Indirizzo
840 MEMORIAL DRIVE, CAMBRIDGE
Confronta MRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRSN
Mersana Therapeutics Inc
|
7.32 | 38.23M | 34.77M | -74.04M | -79.76M | -7.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Mersana Therapeutics Inc Stock (MRSN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-06 | Iniziato | William Blair | Outperform |
| 2024-11-15 | Ripresa | Citigroup | Buy |
| 2024-03-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-02-29 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2024-02-29 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-07-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-07-27 | Downgrade | Citigroup | Buy → Neutral |
| 2023-07-27 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-07-27 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-07-27 | Downgrade | Truist | Buy → Hold |
| 2023-07-27 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-06-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-06-15 | Iniziato | Guggenheim | Buy |
| 2023-03-16 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-01-20 | Iniziato | Citigroup | Buy |
| 2022-11-21 | Iniziato | Truist | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-08-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-03-31 | Iniziato | Credit Suisse | Neutral |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-09-29 | Ripresa | JP Morgan | Neutral |
| 2020-04-29 | Iniziato | BTIG Research | Buy |
| 2020-01-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-03-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-14 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-08 | Iniziato | Robert W. Baird | Outperform |
| 2018-03-19 | Downgrade | JP Morgan | Overweight → Neutral |
Mostra tutto
Mersana Therapeutics Inc Borsa (MRSN) Ultime notizie
What does recent volatility data suggest for Mersana Therapeutics Inc.July 2025 Movers & Daily Stock Trend Reports - Newser
Is Mersana Therapeutics Inc. stock reversal real or fake2025 Momentum Check & Real-Time Market Trend Scan - Newser
What recovery options are there for Mersana Therapeutics Inc.Quarterly Growth Report & Fast Entry Momentum Trade Alerts - Newser
Is Mersana Therapeutics Inc. subject to activist investor interestAnalyst Downgrade & Weekly Momentum Picks - خودرو بانک
How does Mersana Therapeutics Inc. perform in inflationary periods2025 Key Lessons & Daily Price Action Insights - خودرو بانک
Evaluating Mersana Therapeutics Inc. with trendline analysisPortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
Analyzing net buyer seller activity in Mersana Therapeutics Inc.Portfolio Value Summary & Low Risk High Reward Trade Ideas - Newser
Signal strength of Mersana Therapeutics Inc. stock in tech scannersAnalyst Downgrade & Weekly Setup with ROI Potential - Newser
Best data tools to analyze Mersana Therapeutics Inc. stockGold Moves & Precise Entry and Exit Recommendations - Newser
Why Mersana Therapeutics Inc. stock attracts strong analyst attentionWeekly Gains Report & Reliable Intraday Trade Plans - Newser
Can momentum traders help lift Mersana Therapeutics Inc.July 2025 Reactions & High Conviction Investment Ideas - Newser
Can Mersana Therapeutics Inc. recover in the next quarterJuly 2025 Institutional & Weekly Breakout Watchlists - Newser
Developing predictive dashboards with Mersana Therapeutics Inc. data2025 Price Momentum & Advanced Technical Signal Analysis - Newser
Has Mersana Therapeutics Inc. formed a bullish divergenceJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
Is Mersana Therapeutics Inc. reversing from oversold territoryJuly 2025 Patterns & Intraday High Probability Setup Alerts - Newser
Mersana Therapeutics Inc. stock volume spike explainedEarnings Growth Report & Real-Time Chart Breakout Alerts - Newser
Mersana Therapeutics' SVP sells shares worth $4,912 - MSN
Will Mersana Therapeutics Inc. outperform the marketBond Market & Weekly Momentum Stock Picks - Newser
Will Mersana Therapeutics Inc. stock go up soon2025 Investor Takeaways & Safe Entry Momentum Tips - Newser
Using data tools to time your Mersana Therapeutics Inc. exitTrend Reversal & Reliable Entry Point Trade Alerts - Newser
Is it too late to sell Mersana Therapeutics Inc.July 2025 Retail & Verified Short-Term Plans - Newser
Order flow analysis tools used on Mersana Therapeutics Inc.July 2025 Summary & Safe Capital Preservation Plans - Newser
What Fibonacci levels say about Mersana Therapeutics Inc. reboundWeekly Stock Recap & Consistent Growth Stock Picks - Newser
Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet - MSN
What data driven models say about Mersana Therapeutics Inc.’s futureEntry Point & High Return Stock Watch Alerts - Newser
Will Mersana Therapeutics Inc. bounce back from current support2025 Analyst Calls & Reliable Volume Spike Alerts - Newser
Mersana Therapeutics Inc.’s volatility index tracking explainedAnalyst Upgrade & Breakout Confirmation Alerts - Newser
Chart overlay techniques for tracking Mersana Therapeutics Inc.2025 Market WrapUp & Safe Capital Growth Tips - Newser
Ranking Mersana Therapeutics Inc. among high performing stocks via tools2025 Market Trends & Growth Focused Stock Pick Reports - Newser
Full technical analysis of Mersana Therapeutics Inc. stock2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Analyzing recovery setups for Mersana Therapeutics Inc. investorsWatch List & High Accuracy Swing Entry Alerts - Newser
Mersana Therapeutics Inc Azioni (MRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):